| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Qi-Wen Han, Yu-He Yuan, Nai-Hong Che. The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease. Progress in neuro-psychopharmacology & biological psychiatry. vol 96. 2021-01-04. PMID:31442553. |
parkinson's disease (pd) is a neurodegenerative disease and its characteristic is the progressive degeneration of dopaminergic neurons within the substantia nigra (sn) of the midbrain. |
2021-01-04 |
2023-08-13 |
Not clear |
| N V Katolikova, A B Malashicheva, R R Gainetdino. [Cell Replacement Therapy in Parkinson's Disease-History of Development and Prospects for Use in Clinical Practice]. Molekuliarnaia biologiia. vol 54. issue 6. 2020-12-09. PMID:33276357. |
parkinson's disease is a widespread neurodegenerative disease, which is characterized by the death of dopaminergic neurons in the substantia nigra of the midbrain. |
2020-12-09 |
2023-08-13 |
Not clear |
| Jeffrey Kim, Marcel M Daad. Non-cell autonomous mechanism of Parkinson's disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis. Brain research. vol 1722. 2020-10-21. PMID:31330122. |
parkinson's disease (pd) is the second most prevalent neurodegenerative disease, characterized by the loss of the midbrain dopaminergic neurons, which leads to impaired motor and cognitive functions. |
2020-10-21 |
2023-08-13 |
Not clear |
| Laura Hühner, Jennifer Rilka, Ralf Gilsbach, Xiaolai Zhou, Venissa Machado, Björn Spitta. Interleukin-4 Protects Dopaminergic Neurons Frontiers in molecular neuroscience. vol 10. 2020-10-01. PMID:28337124. |
parkinson's disease (pd) is one the most common neurodegenerative disease and is characterized by the progressive loss of midbrain dopaminergic (mda) neurons in the substantia nigra resulting in bradykinesia, tremor, and rigidity. |
2020-10-01 |
2023-08-13 |
Not clear |
| Katrine Fabricius, Pernille Barkholt, Jacob Jelsing, Henrik H Hanse. Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease. Frontiers in neuroanatomy. vol 11. 2020-10-01. PMID:29276478. |
neurodegenerative diseases involve loss of specific neuron types, such as the midbrain tyrosine hydroxylase-positive dopamine neurons in parkinson's disease and in animal models of nigrostriatal degeneration. |
2020-10-01 |
2023-08-13 |
rat |
| Knud Larsen, Jamal Momeni, Leila Farajzadeh, Henrik Callesen, Christian Bendixe. Molecular characterization and analysis of the porcine Biochimie open. vol 3. 2020-10-01. PMID:29450128. |
nurr1 plays an important role in nigrostriatal dopamine neuron development and is therefore implicated in the pathogenesis of neurodegenerative diseases linked to the dopamine system of the midbrain. |
2020-10-01 |
2023-08-13 |
Not clear |
| Nicoletta L Lilli, Delphine Révy, Sandra Robelet, Béatrice Lejeun. Effect of the micro-immunotherapy medicine 2LPARK Degenerative neurological and neuromuscular disease. vol 9. 2020-10-01. PMID:31372089. |
effect of the micro-immunotherapy medicine 2lpark parkinson's disease (pd) is a neurodegenerative disease characterized by motor impairments and resulting from progressive degenerative loss of midbrain dopaminergic (daergic) neurons in the substantia nigra. |
2020-10-01 |
2023-08-13 |
Not clear |
| Sara Brignani, R J Pasterkam. Neuronal Subset-Specific Migration and Axonal Wiring Mechanisms in the Developing Midbrain Dopamine System. Frontiers in neuroanatomy. vol 11. 2020-09-30. PMID:28740464. |
the midbrain dopamine (mda) system is involved in the control of cognitive and motor behaviors, and is associated with several psychiatric and neurodegenerative diseases. |
2020-09-30 |
2023-08-13 |
Not clear |
| Guo-Qing Wang, Dai-Di Li, Chun Huang, Di-Sheng Lu, Chao Zhang, Shao-Yu Zhou, Jie Liu, Feng Zhan. Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation Frontiers in molecular neuroscience. vol 10. 2020-09-30. PMID:29375304. |
icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation parkinson's disease (pd) is one of the most common neurodegenerative diseases characterized with a gradual loss of midbrain substantia nigra (sn) dopamine (da) neurons. |
2020-09-30 |
2023-08-13 |
rat |
| Na Feng, Scott Simanski, Kazi Islam, Linda S Hynan, Thomas Kodadek, Dwight C Germa. Antibody biomarker for de novo Parkinson disease: attempted validation. NPJ Parkinson's disease. vol 4. 2020-09-30. PMID:30211310. |
parkinson disease (pd) is a progressive neurodegenerative disease with motor symptoms that result from degeneration of midbrain dopaminergic neurons. |
2020-09-30 |
2023-08-13 |
human |
| Shane V Hegarty, Aideen M Sullivan, Gerard W O'Keeff. Protocol for evaluation of neurotrophic strategies in Parkinson's disease-related dopaminergic and sympathetic neurons Journal of biological methods. vol 3. issue 3. 2020-09-29. PMID:31453215. |
protocol for evaluation of neurotrophic strategies in parkinson's disease-related dopaminergic and sympathetic neurons parkinson's disease (pd) is a neurodegenerative disease that is characterized by motor and non-motor symptoms which result from the progressive degeneration of nigrostriatal ventral midbrain (vm) dopaminergic (da) neurons, as well as peripheral sympathetic neurons. |
2020-09-29 |
2023-08-13 |
Not clear |
| Gerard W O'Keeffe, Shane V Hegarty, Aideen M Sulliva. Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease. Neuronal signaling. vol 1. issue 2. 2020-09-28. PMID:32714578. |
parkinson's disease (pd) is the second most common neurodegenerative disease, characterized by the degeneration of midbrain dopaminergic (mda) neurons and their axons, and aggregation of α-synuclein, which leads to motor and late-stage cognitive impairments. |
2020-09-28 |
2023-08-13 |
Not clear |
| Tomohisa Doi, Yasuhiro Fujiwara, Hirotoshi Maruyam. [Method for Quantitative Evaluation of the Substantia Nigra Using Phase-sensitive Inversion Recovery in 1.5 T Magnetic Resonance Imaging]. Nihon Hoshasen Gijutsu Gakkai zasshi. vol 76. issue 6. 2020-09-24. PMID:32565513. |
parkinson's disease is a neurodegenerative disease with movement disorders caused by degeneration of the substantia nigra (sn) in the midbrain. |
2020-09-24 |
2023-08-13 |
Not clear |
| Khalid I W Kane, Edinson Lucumi Moreno, Siham Hachi, Moriz Walter, Javier Jarazo, Miguel A P Oliveira, Thomas Hankemeier, Paul Vulto, Jens C Schwamborn, Martin Thoma, Ronan M T Flemin. Automated microfluidic cell culture of stem cell derived dopaminergic neurons. Scientific reports. vol 9. issue 1. 2020-09-21. PMID:30741972. |
parkinson's disease is a slowly progressive neurodegenerative disease characterised by dysfunction and death of selectively vulnerable midbrain dopaminergic neurons and the development of human in vitro cellular models of the disease is a major challenge in parkinson's disease research. |
2020-09-21 |
2023-08-13 |
human |
| Jun Takahash. Preclinical evaluation of patient-derived cells shows promise for Parkinson's disease. The Journal of clinical investigation. vol 130. issue 2. 2020-09-04. PMID:31929191. |
parkinson's disease (pd) is a neurodegenerative disease caused by the progressive loss of dopaminergic (da) neurons in the midbrain projecting to the striatum, which leads to motor dysfunctions, such as bradykinesia (slowed movement), rigidity, and tremors. |
2020-09-04 |
2023-08-13 |
Not clear |
| Sabine Morris Hey, Pia Jensen, Matias Ryding, Alberto Martínez Serrano, Bjarne W Kristensen, Morten Meye. Nonhypoxic pharmacological stabilization of Hypoxia Inducible Factor 1α: Effects on dopaminergic differentiation of human neural stem cells. The European journal of neuroscience. vol 49. issue 4. 2020-06-22. PMID:30471165. |
parkinson's disease is a neurodegenerative disease resulting in degeneration of midbrain dopaminergic neurons. |
2020-06-22 |
2023-08-13 |
human |
| Kiana Rafiepour, Saeed Esmaeili-Mahani, Ali Salehzadeh, Vahid Sheiban. Phytohormone Abscisic Acid Protects Human Neuroblastoma SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Neurotoxicity Through Its Antioxidant and Antiapoptotic Properties. Rejuvenation research. vol 22. issue 2. 2019-11-15. PMID:30091676. |
parkinson's disease (pd) is a destroying and prevalent neurodegenerative disease that is characterized by a progressive death of midbrain dopaminergic neurons. |
2019-11-15 |
2023-08-13 |
human |
| Stephana Carelli, Toniella Giallongo, Zuzana Gombalova, Federica Rey, Maria Carlotta F Gorio, Massimiliano Mazza, Anna Maria Di Giuli. Counteracting neuroinflammation in experimental Parkinson's disease favors recovery of function: effects of Er-NPCs administration. Journal of neuroinflammation. vol 15. issue 1. 2019-03-11. PMID:30501635. |
parkinson's disease (pd) is the second most common neurodegenerative disease, presenting with midbrain dopaminergic neurons degeneration. |
2019-03-11 |
2023-08-13 |
Not clear |
| Fanny Faivre, Anil Joshi, Erwan Bezard, Michel Barro. The hidden side of Parkinson's disease: Studying pain, anxiety and depression in animal models. Neuroscience and biobehavioral reviews. vol 96. 2019-02-11. PMID:30365972. |
parkinson's disease is a neurodegenerative disease leading to the loss of midbrain dopamine neurons. |
2019-02-11 |
2023-08-13 |
Not clear |
| Chun Huang, Fengqin Lin, Guoqing Wang, Disheng Lu, Qin Wu, Jie Liu, Jingshan Shi, Feng Zhan. Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity. Oxidative medicine and cellular longevity. vol 2018. 2018-09-18. PMID:29576855. |
parkinson's disease (pd) was one of the most common neurodegenerative diseases with a slow and progressive loss of dopamine (da) neurons in the midbrain substantia nigra (sn). |
2018-09-18 |
2023-08-13 |
Not clear |